Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Emmanuel Papadakis is an analyst at Deutsche Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/19/2024 | BNTX | Buy Now | BioNTech | $95.90 | 56.41% | Emmanuel Papadakis47% | $95 → $150 | Maintains | Buy | Get Alert |
| 08/07/2024 | BNTX | Buy Now | BioNTech | $95.90 | -0.94% | Emmanuel Papadakis47% | $95 → $95 | Upgrade | Hold → Buy | Get Alert |
| 08/06/2024 | MRNA | Buy Now | Moderna | $31.48 | 154.13% | Emmanuel Papadakis47% | $85 → $80 | Upgrade | Sell → Hold | Get Alert |
| 03/12/2024 | GRFS | Buy Now | Grifols | $7.46 | — | Emmanuel Papadakis47% | — | Downgrade | Hold → Sell | Get Alert |
| 02/08/2024 | AZN | Buy Now | AstraZeneca | $72.73 | — | Emmanuel Papadakis47% | — | Downgrade | Buy → Hold | Get Alert |
| 11/02/2023 | MRNA | Buy Now | Moderna | $31.48 | — | Emmanuel Papadakis47% | — | Downgrade | Hold → Sell | Get Alert |
| 08/03/2023 | MRNA | Buy Now | Moderna | $31.48 | 297.07% | Emmanuel Papadakis47% | $200 → $125 | Downgrade | Buy → Hold | Get Alert |
| 05/18/2023 | BNTX | Buy Now | BioNTech | $95.90 | 25.13% | Emmanuel Papadakis47% | $135 → $120 | Maintains | Hold | Get Alert |
| 04/24/2023 | BNTX | Buy Now | BioNTech | $95.90 | 40.77% | Emmanuel Papadakis47% | $160 → $135 | Maintains | Hold | Get Alert |
| 03/07/2023 | ALVO | Buy Now | Alvotech | $10.50 | 14.29% | Emmanuel Papadakis47% | $8 → $12 | Maintains | Hold | Get Alert |
| 02/28/2023 | MRNA | Buy Now | Moderna | $31.48 | 535.32% | Emmanuel Papadakis47% | $225 → $200 | Maintains | Buy | Get Alert |
| 11/11/2022 | BNTX | Buy Now | BioNTech | $95.90 | 66.84% | Emmanuel Papadakis47% | $180 → $160 | Maintains | Hold | Get Alert |
| 09/08/2022 | MRNA | Buy Now | Moderna | $31.48 | 424.14% | Emmanuel Papadakis47% | $155 → $165 | Upgrade | Hold → Buy | Get Alert |
| 08/12/2022 | SNY | Buy Now | Sanofi | $54.50 | — | Emmanuel Papadakis47% | — | Upgrade | Sell → Hold | Get Alert |
| 07/01/2022 | ALVO | Buy Now | Alvotech | $10.50 | -4.76% | Emmanuel Papadakis47% | → $10 | Initiates | → Hold | Get Alert |
| 06/01/2022 | BNTX | Buy Now | BioNTech | $95.90 | 87.7% | Emmanuel Papadakis47% | → $180 | Maintains | Hold | Get Alert |
| 04/01/2022 | BNTX | Buy Now | BioNTech | $95.90 | 108.55% | Emmanuel Papadakis47% | → $200 | Maintains | Hold | Get Alert |
| 03/16/2022 | NVO | Buy Now | Novo Nordisk | $71.84 | — | Emmanuel Papadakis47% | — | Upgrade | Hold → Buy | Get Alert |
| 03/07/2022 | MRNA | Buy Now | Moderna | $31.48 | 392.37% | Emmanuel Papadakis47% | $175 → $155 | Maintains | Hold | Get Alert |
| 01/26/2022 | MRNA | Buy Now | Moderna | $31.48 | 455.9% | Emmanuel Papadakis47% | → $175 | Upgrade | Sell → Hold | Get Alert |
| 11/09/2021 | BNTX | Buy Now | BioNTech | $95.90 | 134.62% | Emmanuel Papadakis47% | → $225 | Maintains | Hold | Get Alert |
| 11/05/2021 | GRFS | Buy Now | Grifols | $7.46 | — | Emmanuel Papadakis47% | — | Downgrade | Buy → Hold | Get Alert |
| 10/22/2021 | BNTX | Buy Now | BioNTech | $95.90 | 160.69% | Emmanuel Papadakis47% | → $250 | Initiates | → Hold | Get Alert |
| 10/22/2021 | CVAC | Buy Now | CureVac | $2.99 | 1070.57% | Emmanuel Papadakis47% | → $35 | Initiates | → Hold | Get Alert |
| 10/22/2021 | MRNA | Buy Now | Moderna | $31.48 | 694.15% | Emmanuel Papadakis47% | → $250 | Initiates | → Sell | Get Alert |
| 09/20/2021 | NVS | Buy Now | Novartis | $109.05 | — | Emmanuel Papadakis47% | — | Downgrade | Hold → Sell | Get Alert |
| 07/23/2021 | ARGX | Buy Now | argenx | $583.66 | — | Emmanuel Papadakis47% | — | Initiates | → Hold | Get Alert |
| 07/23/2021 | UCBJY | Buy Now | UCB | $89.77 | — | Emmanuel Papadakis47% | — | Initiates | → Buy | Get Alert |
| 07/08/2021 | RHHBY | Buy Now | Roche Holding | $42.63 | — | Emmanuel Papadakis47% | — | Upgrade | Hold → Buy | Get Alert |
| 02/04/2021 | GSK | Buy Now | GSK | $38.01 | — | Emmanuel Papadakis47% | — | Downgrade | Hold → Sell | Get Alert |
| 01/15/2021 | SNY | Buy Now | Sanofi | $54.50 | — | Emmanuel Papadakis47% | — | Initiates | → Sell | Get Alert |
| 01/15/2021 | AZN | Buy Now | AstraZeneca | $72.73 | — | Emmanuel Papadakis47% | — | Initiates | → Buy | Get Alert |
| 01/15/2021 | GSK | Buy Now | GSK | $38.01 | — | Emmanuel Papadakis47% | — | Initiates | → Hold | Get Alert |
| 01/15/2021 | NVS | Buy Now | Novartis | $109.05 | — | Emmanuel Papadakis47% | — | Initiates | → Buy | Get Alert |
| 01/15/2021 | NVO | Buy Now | Novo Nordisk | $71.84 | — | Emmanuel Papadakis47% | — | Initiates | → Buy | Get Alert |
| 06/20/2019 | NVO | Buy Now | Novo Nordisk | $71.84 | — | Emmanuel Papadakis47% | — | Downgrade | Buy → Hold | Get Alert |
| 09/12/2016 | NVO | Buy Now | Novo Nordisk | $71.84 | — | Emmanuel Papadakis47% | — | Upgrade | Hold → Buy | Get Alert |
| 09/14/2015 | AZN | Buy Now | AstraZeneca | $72.73 | — | Emmanuel Papadakis47% | — | Upgrade | Hold → Buy | Get Alert |
| 10/29/2014 | SNY | Buy Now | Sanofi | $54.50 | 43.12% | Emmanuel Papadakis47% | $93 → $78 | Downgrade | Buy → Hold | Get Alert |
| 10/28/2014 | SNY | Buy Now | Sanofi | $54.50 | — | Emmanuel Papadakis47% | — | Downgrade | Buy → Hold | Get Alert |
| 12/17/2013 | GSK | Buy Now | GSK | $38.01 | — | Emmanuel Papadakis47% | — | Downgrade | Buy → Hold | Get Alert |
| 05/28/2013 | GSK | Buy Now | GSK | $38.01 | — | Emmanuel Papadakis47% | — | Upgrade | Hold → Buy | Get Alert |
| 12/12/2012 | NVS | Buy Now | Novartis | $109.05 | — | Emmanuel Papadakis47% | — | Downgrade | Buy → Hold | Get Alert |
